Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M muscarinic acetylcholine receptor
Authors
Bender
AM
Aaron M
,
Carter
TR
Trever R
,
Spock
M
Matthew
,
Rodriguez
AL
Alice L
,
Dickerson
JW
Jonathan W
,
Rook
JM
Jerri M
,
Chang
S
Sichen
,
Qi
A
Aidong
,
Presley
CC
Christopher C
,
Engers
DW
Darren W
,
Harp
JM
Joel M
,
Bridges
TM
Thomas M
,
Niswender
CM
Colleen M
,
Conn
PJ
P Jeffrey
,
Lindsley
CW
Craig W
.
Bioorganic & medicinal chemistry letters. 2021 11 24; 56().
128479
Bioorganic & medicinal chemistry letters. 2021 11 24; 56().
128479
Abstract
In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR). Chiral separation and subsequent X-ray crystallographic analysis of early generation analogs revealed the R enantiomer to possess excellent human and rat M potency, and further structure-activity relationship (SAR) studies on this chiral scaffold led to the discovery of VU6015241 (compound 19). Compound 19 is characterized by high M potency and selectivity across multiple species, excellent aqueous solubility, and moderate brain exposure in rodents after intraperitoneal administration.